Clinical trials
Active, not recruiting Phase 1/2 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2013 | 1 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 7 |
| 2020 | 8 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 5 |
| AstraZeneca | 4 |
| Memorial Sloan Kettering Cancer Center | 3 |
| National University Hospital, Singapore | 3 |
| Eli Lilly and Company | 2 |
| Novartis Pharmaceuticals | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Acerand Therapeutics (Shanghai) Limited | 1 |
| Antonio Giordano, MD | 1 |
| BicycleTx Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 48 |
| Triple Negative Breast Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Prostatic Neoplasms | 6 |
| Ovarian Neoplasms | 5 |
| Lung Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Small Cell Lung Carcinoma | 4 |
| Brain Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.